Basit öğe kaydını göster

dc.contributor.authorGee, Heon Yung
dc.contributor.authorAshraf, Shazia
dc.contributor.authorWan, Xiaoyang
dc.contributor.authorVega-Warner, Virginia
dc.contributor.authorEsteve-Rudd, Julian
dc.contributor.authorLovric, Svjetlana
dc.contributor.authorFang, Humphrey
dc.contributor.authorHurd, Toby W.
dc.contributor.authorSadowski, Carolin E.
dc.contributor.authorAllen, Susan J.
dc.contributor.authorOtto, Edgar A.
dc.contributor.authorKorkmaz, Emine
dc.contributor.authorWashburn, Joseph
dc.contributor.authorLevy, Shawn
dc.contributor.authorWilliams, David S.
dc.contributor.authorBakkaloglu, Sevcan A.
dc.contributor.authorZolotnitskaya, Anna
dc.contributor.authorOzaltin, Fatih
dc.contributor.authorZhou, Weibin
dc.contributor.authorHildebrandt, Friedhelm
dc.date.accessioned2019-12-16T07:57:00Z
dc.date.available2019-12-16T07:57:00Z
dc.date.issued2014
dc.identifier.issn0002-9297
dc.identifier.urihttps://doi.org/10.1016/j.ajhg.2014.04.010
dc.identifier.urihttp://hdl.handle.net/11655/19330
dc.description.abstractNephrotic syndrome (NS) is a genetically heterogeneous group of diseases that are divided into steroid-sensitive NS (SSNS) and steroid-resistant NS (SRNS). SRNS inevitably leads to end-stage kidney disease, and no curative treatment is available. To date, mutations in more than 24 genes have been described in Mendelian forms of SRNS; however, no Mendelian form of SSNS has been described. To identify a genetic form of SSNS, we performed homozygosity mapping, whole-exome sequencing, and multiplex PCR followed by next-generation sequencing. We thereby detected biallelic mutations in EMP2 (epithelial membrane protein 2) in four individuals from three unrelated families affected by SRNS or SSNS. We showed that EMP2 exclusively localized to glomeruli in the kidney. Knockdown of emp2 in zebrafish resulted in pericardial effusion, supporting the pathogenic role of mutated EMP2 in human NS. At the cellular level, we showed that knockdown of EMP2 in podocytes and endothelial cells resulted in an increased amount of CAVEOLIN-1 and decreased cell proliferation. Our data therefore identify EMP2 mutations as causing a recessive Mendelian form of SSNS.
dc.language.isoen
dc.publisherCell Press
dc.relation.isversionof10.1016/j.ajhg.2014.04.010
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectGenetics & Heredity
dc.titleMutations In Emp2 Cause Childhood-Onset Nephrotic Syndrome
dc.typeinfo:eu-repo/semantics/article
dc.relation.journalAmerican Journal Of Human Genetics
dc.contributor.departmentBiyoloji
dc.identifier.volume94
dc.identifier.issue6
dc.identifier.startpage884
dc.identifier.endpage890
dc.description.indexWoS
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster